EMA Withdrawn: Granupas (previously Para-aminosalicylic acid Lucane) (para-aminosalicylic acid) — Eurocept International B. V.

View source ↗

Summary

The EMA has withdrawn Granupas, a para-aminosalicylic acid product, from the European market for tuberculosis treatment. The decision date is 14/08/2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Granupas (para-aminosalicylic acid)

Snippet

Status: Withdrawn. Therapeutic area: Tuberculosis. MAH: Eurocept International B. V.. Decision date: 14/08/2024